European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Bayer AG, Leverkusen, Germany

Innovation Champion DE Commercial # 58
Watch
Bayer AG

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier is a comprehensive company details as a PDF and publications in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Complete Dossier
Entire company details along with publications bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more
Learn more
View plans
Risk report
Bayer AG
Risk Level Evaluation Source
Sanctioned (?)

Name

Bayer AG
Bayer AG Buiv

Identification

Ut
District Court of Cologne HRB 48248
Kbo
Crossroads Bank for Enterprises (KBO) 0413.408.654
PT
PT 980078598
Stockp
BAY.WA BAYN.SG BAYRY BAYN.DE BAYN.SW BAYNN.MX
Lei
549300J4U55H3WP1XT59
EUID
DER3306.HRB48248

Address

Kaiser-Wilhelm-Allee 1, 51373 Leverkusen, Germany

Corporate purpose

The object of the company is production, distribution, other industrial activity or provision of services in the fields of health and agriculture. The Company may also provide these activities in the fields of polymers and chemicals.

Financial performance

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Persons

Marketing & Tech

Merger & Acquisition & Control

Network

Loading network

Legal Structure

Current legal representatives Legal form information · Proxy policies Premium
Premium
1CEO
5Member of the Executive Board
127Authorized signatory (ppa)
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

DATA SERVICES

Unlock the full potential of processed company data with our API or Quarterly Exports.

Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Portfolio and Investments
31 known active shareholdings
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Earnings
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Return on equity
Taxes
Cash on hand
Receivables
Liabilities
Number of public fundings
Total public funding
Trademarks
Patents
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
Annual report
 
Financial Statements Interactive sheets with CSV/Excel download Premium
Premium
Balance
from 2005 to 2025
Profit & Loss
from 2005 to 2025
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Publications

Year 2026 in Epobase
48 European patent filings: N-(1,3,4-Oxadiazol-2-YL)Phenylcarboxamides AS Herbicides …
30 Jul 2026
Shareholdings: Natsana GmbH, Perfuse Therapeutics Inc
Year 2026 in Euipotm
59 trademark filings (53 wordmarks, 2 figurative marks, 4 word figurative marks): #nototwo, 4CONVISOMIX, ALLAMVY, AMAVUW, AMMSQAN, AMNAVUW, AMREVEAL, AMSENZYL, AMSIGNYL, AMULOY, AMULVIEW, AMVULUK …
13 Jul 2026 in Hor
EU funding (€290,272): Molecularly Designed Polymers for Sustainable Agriculture
30 Jun 2026
Authorized signatory (ppa) (1)
11 Jun 2026
Figurative mark: “Figurative“
8 Jun 2026
No longer Member of the Executive Board: Wolfgang Nickl · No longer Authorized signatory (ppa) (2) · Authorized signatory (ppa) (2)
5 May 2026
List of board members
1 May 2026 via AbbVie Deutschland GmbH & Co. KG
EU funding: FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE
29 Apr 2026
Aufsichtsrat
27 Apr 2026
Dividendenbekanntmachung
24 Apr 2026
Original document: “Liste der Aufsichtsratsmitglieder zum 24.04.2026“
11 Apr 2026
Patent: Methods for treating flue gas
23 Mar 2026
Consolidated Annual report for the year ending 31/12/2025 · Balance sheet for 31/12/2025 · Earnings statement for 31/12/2025
11 Mar 2026
Member of the Executive Board: Judith Hartmann
10 Mar 2026
Authorized signatory (ppa): Max Georg Thümmel, Hartwig Wendt · No longer Authorized signatory (ppa) (1)
4 Mar 2026
Einberufung der ordentlichen Hauptversammlung
4 Mar 2026
Wordmark: “EFILIA“
27 Feb 2026 also 19/12/2025
Ultimate parent: The Goldman Sachs Group Inc
13 Feb 2026
Authorized signatory (ppa): Julian Egger, Claudia Letmathe · No longer Authorized signatory (ppa) (3)
7 Feb 2026
European Union Transparency Register
29 Jan 2026
No longer Authorized signatory (ppa) (7)
21 Jan 2026
Ultimate parent: BlackRock Inc
15 Jan 2026
Antitrust Investigation: Bayer AG
31 Dec 2025
Balance sheet for 31/12/2025 · Earnings statement for 31/12/2025
Year 2025 in Epobase
70 European patent filings: Masp-inhibiting compounds and their uses …
Year 2025 in Euipotm
57 trademark filings (51 wordmarks, 2 figurative marks, 4 word figurative marks): AKAMIKA, AMTERBY, ARNUVEQS, AUMBEYA, AVANDER, BEYONPLUS, BORESO, BUZMIQA, CEQOLZI, CEYAVI, CIHIRVI, CYCERVY, CYHIRVI …
18 Nov 2025
Authorized signatory (ppa): Christoph Abendroth, Meike Pfrötzschner · No longer Authorized signatory (ppa) (8)
17 Nov 2025
Consolidated Annual report for the year ending 31/12/2025
17 Nov 2025 also 15/01/2025, 04/01/2024
Hinweis auf Halbjahresfinanzbericht vom 01.01.2026 bis zum 30.06.2026
17 Nov 2025 also 15/01/2025
Hinweis auf Jahresfinanzbericht vom 01.01.2025 bis zum 31.12.2025
23 Sept 2025
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (2)
29 Aug 2025 via Croplife Europe VZW
Auditor: Croplife Europe VZW
6 Aug 2025
Authorized signatory (ppa) (5) · No longer Authorized signatory (ppa) (5)
31 Jul 2025
Half-year financial report according to WpHG for the financial year from 01.01.2025 to 30.06.2025
Year 2025 in Dpmap
4 patent filings: Methods for treating flue gas …
Year 2025 in Euipods
15 registered designs
5 Jun 2025
Wordmark: “BAYFOMOX“
14 May 2025
No longer Authorized signatory (ppa) (4)
13 May 2025
Authorized signatory (ppa): Milton Antonio Filho, Martina Peters · No longer Authorized signatory (ppa) (7)
9 May 2025
Legal form: The Annual General Meeting of 25.04.2025 resolved to amend § 4 (share capital) para …
2 May 2025
Wordmark: “BAYMAIL“
1 May 2025 via Actelion Pharmaceuticals Ltd.
EU funding: Testing, improving, and co-creating Guidance and Tools for Real World Evidence Generation in Europe and use for Decision-Making in Europe: GREG
25 Apr 2025
Original document: “Gesellschaftsvertrag / Satzung / Statut“
8 Apr 2025
Consolidated Annual report for the year ending 31/12/2024 · Balance sheet for 31/12/2024 · Earnings statement for 31/12/2024
7 Apr 2025
Member of the Executive Board: Julio Triana · Authorized signatory (ppa): Morris Leckebusch · No longer Authorized signatory (ppa) (2)
25 Mar 2025 in Sat
State Aid (€500,000 - €1,000,000): Germany - Evaluation plan for the block exempted R&D tax incentive scheme "Forschungszulagengesetz"
7 Mar 2025
Einberufung der ordentlichen Hauptversammlung
25 Feb 2025
Authorized signatory (ppa): Dora Congost, Maik Eckelmann
21 Feb 2025
Ultimate parent: Dodge & Cox
17 Feb 2025
Authorized signatory (ppa) (10) · No longer Authorized signatory (ppa) (17)
17 Feb 2025
List of board members
15 Jan 2025
Consolidated Annual report for the year ending 31/12/2024
9 Jan 2025
Aufsichtsrat
7 Jan 2025
Original document: “Liste der Aufsichtsratsmitglieder zum 07.01.2025“
31 Dec 2024
Balance sheet for 31/12/2024 · Earnings statement for 31/12/2024
Year 2024 in Epobase
118 European patent filings: Method for the production of a 2,4,5-trisubstituted 1,2,4-triazolone …
Year 2024 in Hor
7 EU fundings (€359,914): Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases …
Year 2024 in Euipotm
57 trademark filings (53 wordmarks, 2 figurative marks, 2 word figurative marks): AFSUNZI, AFZUNSI, AVZUNSI, BAYER - HEALTH FOR ALL, HUNGER FOR NONE, BLOOMONDO, CHEVALIER, CHOCKER, CRYOSNAP, DECIS …
3 Dec 2024
Authorized signatory (ppa): Marc Ch. Vathauer · No longer Authorized signatory (ppa) (5)
28 Nov 2024 via Croplife Europe VZW
Director: Croplife Europe VZW
19 Nov 2024
Authorized signatory (ppa): Heike Hardelauf, Regine Jürgens · No longer Authorized signatory (ppa) (5)
15 Oct 2024
Authorized signatory (ppa) (8)
Year 2024 in Euipods
7 registered designs
12 Sept 2024
Authorized signatory (ppa): Anastasia Hager, Maria Ch. Kruett
12 Sept 2024
Aufsichtsrat
12 Sept 2024
List of board members
10 Sept 2024
Original document: “Liste der Aufsichtsratsmitglieder zum 10.09.2024“
22 Aug 2024
No longer Authorized signatory (ppa) (2)
6 Aug 2024
Consolidated Annual report for the year ending 30/06/2024 · Balance sheet for 30/06/2024 · Shareholding: Bayer AG
25 Jul 2024 via SQD.AI Strategies AG
Shareholder: Heidelberger Beteiligungsholding AG
17 Jul 2024
Authorized signatory (ppa): Maik Eckelmann, Jutta Pospisil · No longer Authorized signatory (ppa) (6)
2 Jul 2024
Antitrust Investigation: Bayer AG, Natsana GmbH
26 Jun 2024
Authorized signatory (ppa): Eun Young Lee · No longer Authorized signatory (ppa) (1)
20 Jun 2024 via Conseil Europeen de l'Industrie Chimique - European Chemical Industry Council VZW
No longer Member of the board: Conseil Europeen de l'Industrie Chimique - European Chemical Industry Council VZW
13 Jun 2024
Patent: Determination of the usage status of a device for single administration of medicinal substances
6 Jun 2024
Wordmark: “BETA-ADALAT“
8 May 2024
Member of the Executive Board: Julio Triana · No longer Member of the Executive Board: Heiko Schipper · Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (4)
7 May 2024
Aufsichtsrat
6 May 2024
List of board members
30 Apr 2024
Original document: “Liste der Aufsichtsratsmitglieder zum 30.04.2024“
29 Apr 2024
Dividendenbekanntmachung
29 Apr 2024
Mitteilung gemäß § 49 Abs. 1 Satz 1 Nr. 2 WpHG - Ermächtigung zum Erwerb und zur Verwendung eigener Aktien unter Ausschluss des Bezugsrechts
15 Apr 2024
Member of the Executive Board: Julio Triana
10 Apr 2024
Consolidated Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023
5 Apr 2024
Authorized signatory (ppa): Martin van Eickels · No longer Authorized signatory (ppa) (1)
1 Apr 2024 in Fk
Public funding (€109,792): Alternative Methods: Digital Patterns for the Detection and Prediction of Chemically Induced Endocrine Disruption in Fish (DiMEP) - Literature & Experimental Works
1 Apr 2024 in Fk
Public funding (€109,792): Alternative Methods: Digital Patterns for the Detection and Prediction of Chemically Induced Endocrine Disruption in Fish (DiMEP) - Literature & Experimental Works
11 Mar 2024
Einberufung der ordentlichen Hauptversammlung
5 Mar 2024
Authorized signatory (ppa): Daniel Schwabe
5 Mar 2024 also 25/02/2021
Reference to annual financial report from 01.01.2023 to 31.12.2023
16 Feb 2024
Authorized signatory (ppa): Thomas Wessa
16 Jan 2024
Patent: Methods for treating flue gas
12 Jan 2024
Authorized signatory (ppa) (4) · No longer Authorized signatory (ppa) (6)
4 Jan 2024
Consolidated Annual report for the year ending 31/12/2023
2 Jan 2024 via antea InvAG mit veränderlichem Kapital und Teilgesellschaftsvermögen
Shareholder: antea InvAG mit veränderlichem Kapital und Teilgesellschaftsvermögen
31 Dec 2023
Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023
29 Dec 2023
No longer Authorized signatory (ppa) (8)
Year 2023 in Epobase
105 European patent filings: Compositions and methods for delivering transgenes …
Year 2023 in Euipotm
49 trademark filings (44 wordmarks, 2 figurative marks, 3 word figurative marks): ABRILLON, ACTARGO, ANZILON, ARQITE, ARTENIGO, ARTOVIGA, ATELIETTE, AVENKEN, BELYSIS, BIITUDE, CARDICENT, CENTAFORE …
9 Nov 2023
Utility patent: Housing segment for a device for use on agricultural land
25 Oct 2023
Authorized signatory (ppa) (5)
5 Oct 2023
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
1 Oct 2023 via Eli Lilly Export SA
EU funding: INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE
28 Sept 2023
Patent: Benazolincholin und Dessen Verwendung im Agrochemischen Feld
8 Sept 2023
Member of the Executive Board: Heike Prinz · No longer Member of the Executive Board: Sarena Lin · No longer Authorized signatory (ppa): Heike Prinz
14 Aug 2023
Authorized signatory (ppa) (6) · No longer Authorized signatory (ppa) (2)
8 Aug 2023 via Bayer Portugal Lda.
Shareholding: Bayer Portugal Lda
8 Aug 2023
Shareholding: Bayer AG
8 Aug 2023 also 04/08/2020
Reference to half-year financial report from 01.01.2023 to 30.06.2023
24 Jul 2023 via ALTAMIRA LLC
EU funding (€390,809): Explainable AI for Molecules - AiChemist
Year 2023 in Dpmam
13 figurative marks
29 Jun 2023 in Hor
EU funding: Sharing and re-using clinical trial data to maximise impact
28 Jun 2023
Authorized signatory (ppa): Diane Carini, Sreeparna Kurdikar · No longer Authorized signatory (ppa) (3)
21 Jun 2023 via Conseil Europeen de l'Industrie Chimique - European Chemical Industry Council VZW
Director: Conseil Europeen de l'Industrie Chimique - European Chemical Industry Council VZW
7 Jun 2023
Member of the Executive Board: William N. Anderson · No longer Member of the Executive Board: Werner Baumann
6 Jun 2023
Company statute
2 May 2023
No longer Authorized signatory (ppa) (2)
2 May 2023
Dividendenbekanntmachung
1 May 2023 in Fk
Public funding (€23,594): ETOS: Development and Analysis of a Large-Scale Electrolyzer for Long-Term Operation (EAGLE) - B
28 Apr 2023
Original document: “Gesellschaftsvertrag / Satzung / Statut“
11 Apr 2023
Member of the Executive Board: William N. Anderson
1 Apr 2023 in Fk
Public funding (€73,500): Alternative methods: Development and validation of an SOP for the prediction of drug-induced cholestasis (MEDIATOR) - Phenotypic characterization in liver models
1 Apr 2023 in Fk
Public funding (€73,500): Alternative methods: Development and validation of an SOP for the prediction of drug-induced cholestasis (MEDIATOR) - Phenotypic characterization in liver models
3 Mar 2023
Authorized signatory (ppa): Ruedeger Koehler · No longer Authorized signatory (ppa) (2)
2 Mar 2023
Einberufung der ordentlichen Hauptversammlung
28 Feb 2023 also 01/03/2022, 17/02/2020
Reference to Annual Financial Report from 01.01.2022 to 31.12.2022
15 Feb 2023
Consolidated Annual report for the year ending 31/12/2022
10 Feb 2023
Authorized signatory (ppa) (3)
3 Jan 2023
Patent: Pill dispenser with dosing aid
1 Jan 2023 in Fts
EU funding (€245,865): 101083563 - DS4Health - Digital Skills for Healthcare Transformation
31 Dec 2022
Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022
Year 2022 in Epobase
117 European patent filings: Process for Preparing (5S)-{[2-(4-Carboxyphenyl)Ethyl] 2-(2-{ 3-Chloro-4'-(Trifluoromethyl)Biphenyl-4- YL]Methoxy}Phenyl)Ethyl]Aminol-5,6,7,8-Tetrahydroquinoline-2 …
Year 2022 in Euipotm
110 trademark filings (108 wordmarks, 2 word figurative marks): ACCUITY, AFFIRMA, AMBELVIST, AMPLEO, ANTRACOL, AQUITY, AQUR, AQURA, ARQTIXXI, AUMZY, AccuOne, BAYERONE, BREONIQ, BRODAL, CALIGULA …
14 Dec 2022
Authorized signatory (ppa) (3)
12 Dec 2022 via Pallas Versicherung AG also 16/12/2021, 09/02/2021, 17/12/2018, 02/01/2018, 05/10/2016, 07/12/2015, 10/02/2015, 21/07/2010, 13/11/2009, 20/10/2008
Shareholding: Pallas Versicherung AG
28 Nov 2022
No longer Authorized signatory (ppa) (4)
Year 2022 in Hor
6 EU fundings (€187,747): a research and InNOvation Partnership for enhancing the surveillance and control of mosquito VECtors of emerging arboviruses …
2 Nov 2022
Aufsichtsrat
1 Nov 2022 in Fk
Public funding (€81,900): Marker-free high-content analyses based on automated, coherent Raman microscopy (AutoRamanHCA) - Subproject: Evaluation and benchmarking of Raman microscopy as a novel …
27 Oct 2022
List of board members
24 Oct 2022
Original document: “Liste der Aufsichtsratsmitglieder zum 24.10.2022“
12 Oct 2022
List of board members
22 Sept 2022
Authorized signatory (ppa) (2)
9 Sept 2022
Aufsichtsrat
5 Sept 2022
Original document: “Liste der Aufsichtsratsmitglieder zum 05.09.2022“
23 Aug 2022
Authorized signatory (ppa): Dirk Pott, Astrid Scherer · No longer Authorized signatory (ppa): Martin van Eickels
4 Aug 2022
Shareholdings: Natsana GmbH, Noria Therapeutics Inc., Psma Therapeutics Inc
22 Jun 2022
Patent: Benazolincholin und Dessen Verwendung im Agrochemischen Feld
19 May 2022
Consolidated Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021
18 May 2022
Authorized signatory (ppa): Miriam Holstein · No longer Authorized signatory (ppa) (1)
6 May 2022
List of board members
3 May 2022
Original document: “Liste der Aufsichtsratsmitglieder zum 03.05.2022“
26 Apr 2022
Authorized signatory (ppa) (4) · No longer Authorized signatory (ppa) (3)
25 Apr 2022
Hinweis auf Halbjahresfinanzbericht vom 01.01.2022 bis 30.06.2022
21 Apr 2022 via Covestro AG also 05/05/2020, 15/04/2019, 17/04/2018
Shareholding: Covestro AG
22 Mar 2022
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (3)
8 Feb 2022
Registered Design: Railway carriages (part of -)
8 Feb 2022
Registered Design: Railway carriages (part of -)
1 Feb 2022
No longer Authorized signatory (ppa) (11) · Authorized signatory (ppa) (1)
18 Jan 2022
Patent: Simultane Bilddarstellung von zwei unterschiedlichen funktionellen Bereichen
7 Jan 2022
Member of the Executive Board: Rodrigo Peixoto · No longer Member of the Executive Board: Liam Condon
6 Jan 2022
Word figurative mark: “MOVINGONCOLOGY Wissenschaft in Bewegung“
31 Dec 2021
Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021
23 Dec 2021
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (6)
Year 2021 in Epobase
139 European patent filings: Substituted 6-(1H-Pyrazol-1-YL)Pyrimidin-4-Amine Derivatives and Uses Thereof …
Year 2021 in Euipotm
81 trademark filings (79 wordmarks, 2 word figurative marks): ADTRAKVA, ADTRKVA, ADTRKVI, AGENIOM, ALZALUMA, ALZITRACE, ANURIS, ATEVIOR, AVENKEN, AYOVERSE, BALLAD, BAYSURE, BELUGO, BIMEEQ, CADOU …
Year 2021 in Dpmap
7 patent filings: Pill dispenser with dosing aid …
12 Nov 2021
Authorized signatory (ppa) (10) · No longer Authorized signatory (ppa) (5)
Year 2021 in Hor
5 EU fundings (€931,165): FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem …
17 Sept 2021
Authorized signatory (ppa): Matthias Hartisch, Tobias Lücke · No longer Authorized signatory (ppa) (3)
3 Sept 2021
Annual report for the year ending 30/06/2021 · Balance sheet for 30/06/2021 · Earnings statement for 30/06/2021
9 Aug 2021
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (1)
5 Aug 2021
Reference to Half-Year Financial Report from 01.01.2021 to 30.06.2021
30 Jun 2021
Authorized signatory (ppa): Thomas Bieringer
29 Jun 2021
Member of the Executive Board: Sarena Lin · Authorized signatory (ppa): Thomas Bieringer, Maik Eckelmann · No longer Authorized signatory (ppa) (1)
23 Jun 2021
Annual and consolidated financial statements for the financial year from 01.01.2020 to 31.12.2020
31 May 2021
Company statute
17 May 2021
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (1)
12 May 2021
List of board members
7 May 2021
Original document: “Liste der Aufsichtsratsmitglieder zum 07.05.2021“
6 May 2021
Wordmark: “"Baykanol"“
1 May 2021 in Fk
Public funding (€664,957): COVID-19: CCR1 antagonist for the treatment of hospitalized COVID-19 patients (CATCOVID) - synthesis and upscaling of the drug candidate
1 May 2021 in Fk
Public funding (€913,370): COVID-19: CCR1 antagonist for the treatment of hospitalized COVID-19 patients (CATCOVID) - synthesis and upscaling of the drug candidate
27 Apr 2021
Original document: “Gesellschaftsvertrag / Satzung / Statut“
22 Apr 2021
No longer Authorized signatory (ppa) (3)
1 Apr 2021
Authorized signatory (ppa) (5) · No longer Authorized signatory (ppa) (3)
22 Feb 2021
Member of the Executive Board: Sarena Lin
22 Feb 2021
No longer Authorized signatory (ppa) (8)
16 Feb 2021
Hinweis auf Halbjahresfinanzbericht vom 01.01.2020 bis zum 31.12.2020
12 Feb 2021
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (2)
3 Feb 2021 via Bayer-Handelsgesellschaft mbH
Profit Transfer, Merger: Bayer-Handelsgesellschaft mbH
3 Feb 2021 via TravelBoard GmbH
Control, Profit Transfer, Merger: TravelBoard GmbH
31 Dec 2020
Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020
29 Dec 2020
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (2)
Year 2020 in Epobase
152 European patent filings: Aqueous capsule suspension concentrates based on polyurea shell material with polyfunctional aminocarboxylic acid esters …
14 Dec 2020
Merger: Bayer Business Services GmbH
Year 2020 in Hor
14 EU fundings (€884,759): Central Repository for Digital Pathology …
Year 2020 in Euipotm
58 trademark filings (54 wordmarks, 2 figurative marks, 2 word figurative marks): ALEVIS, AYORAX, AYOVERSE, AllThingsPharma, CALANTIC, CAMBRIVA, CEMBRIUS, COVEZE, EMOVA, ESCAPE, EXAYAM, FLOWCYCLO …
10 Nov 2020
Merger: Bayer Business Services GmbH
29 Oct 2020
Authorized signatory (ppa) (6) · No longer Authorized signatory (ppa) (4)
26 Oct 2020
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
26 Oct 2020
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
26 Oct 2020
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
26 Oct 2020
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
26 Oct 2020
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
26 Oct 2020
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
26 Oct 2020
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
1 Oct 2020
Patent: Pill dispenser with dosing aid
17 Sept 2020
List of board members
10 Sept 2020 in Fk
Public funding (€66,935): INSPIRATION - Qualified, open system pharmacology Modeling network of drug-gene interactions - German subproject B
9 Sept 2020
Original document: “Liste der Aufsichtsratsmitglieder zum 09.09.2020“
7 Sept 2020
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (7)
7 Aug 2020
Consolidated Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019 · Shareholdings (485 companies)
4 Aug 2020 via Elanco Animal Health GmbH
No longer Control: Bayer Animal Health GmbH
4 Aug 2020
Shareholdings: BlueRock Therapeutics LP, Century Therapeutics LLC
29 Jun 2020
Member of the Executive Board: Wolfgang Nickl · Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (5)
24 Jun 2020
Patent: Pill dispenser with dosing aid
22 Jun 2020
Registered Design: Figures
22 Jun 2020
Registered Design: Canisters
3 Jun 2020
Company statute
20 May 2020
Member of the Executive Board: Heiko Schipper · Authorized signatory (ppa) (9) · No longer Authorized signatory (ppa) (9)
29 Apr 2020
Original document: “Liste der Aufsichtsratsmitglieder zum 29.04.2020“
28 Apr 2020
Original document: “Gesellschaftsvertrag / Satzung / Statut“
1 Apr 2020 in Fk
Public funding (€158,738): KEEN - AI Incubator Laboratories in the Process Industry Subproject: KIEP - AI Along the Life Cycle of Production Plants in the Life Science Environment
30 Mar 2020
Patent: Pill dispenser with dosing aid
25 Mar 2020
Authorized signatory (ppa) (7) · No longer Authorized signatory (ppa) (2)
17 Feb 2020
Word figurative mark: “uro SNACK“
1 Feb 2020 in Fk
Public funding (€4,837.00): 'Robust and selective lipolytic biocatalysts for industrial applications (LipoBiocat) - Subproject D'
24 Jan 2020
List of board members
17 Jan 2020
No longer Member of the Executive Board: Hartmut Klusik, Kemal Zulfiqar Malik · Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (7)
6 Jan 2020
Figurative mark: “Figurative“
6 Jan 2020
Figurative mark: “Figurative“
31 Dec 2019
Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019
Year 2019 in Epobase
191 European patent filings: Capsule suspension concentrates based on polyisocyanates and biodegradable amine-based crosslinker …
20 Dec 2019
Due to the conditional increase in the share capital (conditional capital 2014) resolved on 29.04.2014, ...
20 Dec 2019
Original document: “Liste der Aufsichtsratsmitglieder zum 20.12.2019“
Year 2019 in Euipotm
45 trademark filings (32 wordmarks, 8 figurative marks, 5 word figurative marks): ADDURA, ARTOLGIS, BISENO, CAMBALIO, CAPAXOR, DELION, DESTINY, DINASTIA, HABI, HILAGO, JETTANO, KULIANEM, LARENAL …
13 Dec 2019
Original document: “Gesellschaftsvertrag / Satzung / Statut“
29 Nov 2019
Patent: Kontrastmittelbasierte Gefäßdarstellung
29 Nov 2019
Patent: Simultane Bilddarstellung von zwei unterschiedlichen funktionellen Bereichen
27 Nov 2019
Authorized signatory (ppa) (9) · No longer Authorized signatory (ppa) (2)
Year 2019 in Dpmam
77 trademark filings (4 wordmarks, 13 figurative marks, 1 word figurative mark): ADEMSOS, AIM - Assistant for Office Management, AKAMIKA, APUDISA, ARTIMSA, ARTOLGIS, BAYOPX, BRACELIA, BRECELIA …
20 Oct 2019
Patent: Wechselbares Prozessfenster
10 Oct 2019
Original document: “Liste der Aufsichtsratsmitglieder zum 10.10.2019“
Year 2019 in Hor
10 EU fundings (€44,776): Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies …
18 Sept 2019
Authorized signatory (ppa) (5) · No longer Authorized signatory (ppa) (2)
23 Aug 2019
Authorized signatory (ppa) (5) · No longer Authorized signatory (ppa) (6)
31 Jul 2019
Registered Design: Bottles
31 Jul 2019
Registered Design: Bottles
27 Jun 2019
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (3)
29 May 2019
Original document: “Gesellschaftsvertrag / Satzung / Statut“
22 May 2019
Consolidated Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018 · Shareholdings (511 companies)
1 Apr 2019 in Fk
Public funding (€323,047): OSMOSES Open-Source Modeling and Simulation Platform with Automated Quality Control for the Development of Complex System Models in the Life Sciences - Subproject B
1 Apr 2019 in Fk
Public funding (€603,523): Automated STED Nanoscopy for Cell Biological High-Throughput Analyses (ScreeningSTED) - Subproject: New Concepts for Computer-Aided Image Analysis for STED High-Throughput …
20 Mar 2019
No longer Authorized signatory (ppa) (2) · Authorized signatory (ppa) (2)
13 Mar 2019
Authorized signatory (ppa) (1)
15 Feb 2019
No longer Authorized signatory (ppa) (5) · Authorized signatory (ppa) (2)
25 Jan 2019 via Currenta GmbH & Co. OHG also 02/02/2018, 26/10/2015, 20/03/2015, 23/12/2013
Shareholder: Currenta GmbH & Co. OHG
31 Dec 2018
Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018
Year 2018 in Epobase
141 European patent filings: active ingredient combination …
Year 2018 in Dpmam
225 trademark filings (50 wordmarks, 8 figurative marks, 4 word figurative marks): "Comital", ADATEEP, ADENGO, ADTRACE, AFORTIX, AFORTIXA, ALPHARADIN, AMBITION, AMYLERT, AMYLOTRACE, AMYTRACE, APLEEK …
20 Dec 2018
Patent: Substituierte Pyrrolopyridinderivate ALS MAP4K1-Modulatoren zur Behandlung von Krebserkrankungen
19 Dec 2018
Authorized signatory (ppa): Antje Thiele, Ralf Wischnat · No longer Authorized signatory (ppa) (2)
Year 2018 in Euipotm
85 trademark filings (74 wordmarks, 3 figurative marks, 8 word figurative marks): AIRDRIVER, AIRSPACE, APVILIZE, BAYDOTS, BAYER, CYGEMPIC, DALIBRY, DARNALIN, DETEKTRAP, ECPRIA, ENYTHA, EVIDALIS …
7 Dec 2018 via Bayer Pharma AG also 04/01/2017, 28/12/2016
Company lease: Bayer Pharma AG
Year 2018 in Hor
13 EU fundings (€529,687): European Screening Centre; Unique Library for Attractive Biology …
28 Nov 2018
Member of the Executive Board: Stefan Oelrich · No longer Member of the Executive Board: Dieter Weinand
5 Nov 2018
No longer Authorized signatory (ppa) (6)
17 Aug 2018
Authorized signatory (ppa) (4) · No longer Authorized signatory (ppa) (1)
26 Jul 2018
No longer Authorized signatory (ppa) (2) · Authorized signatory (ppa) (1)
Year 2018 in Euipods
10 registered designs
19 Jun 2018
On the basis of the authorization granted by the resolution of the Annual General Meeting of 29.04.2014 - Authorized …
13 Jun 2018
No longer Member of the Executive Board: Johannes Dietsch · No longer Authorized signatory (ppa) (2) · Authorized signatory (ppa) (2)
3 Jun 2018
Original document: “Gesellschaftsvertrag / Satzung / Statut“
30 May 2018
Original document: “Liste der Aufsichtsratsmitglieder zum 30.05.2018“
25 May 2018
Annual report for the year ending 31/12/2017
9 May 2018
Member of the Executive Board: Wolfgang Nickl
25 Apr 2018
No longer Member of the Executive Board: Erica Mann · Authorized signatory (ppa) (8) · No longer Authorized signatory (ppa) (1)
25 Apr 2018
Consolidated Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017 · Shareholdings (340 companies)
25 Apr 2018
Ultimate parent: Government of the Republic of Singapore
19 Apr 2018
Utility patent: Anti-angiogenic substances for the treatment of equine recurrent uveitis
18 Apr 2018
On the basis of the authorization granted by resolution of the Annual General Meeting of 29.04.2014 (Authorized Capital …
17 Apr 2018
Original document: “Gesellschaftsvertrag / Satzung / Statut“
16 Apr 2018
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017 · Shareholdings (333 companies)
13 Mar 2018
Member of the Executive Board: Heiko Schipper · Authorized signatory (ppa): Bernd Heinrich · No longer Authorized signatory (ppa) (1)
12 Mar 2018
Utility patent: Anti-angiogenic substances for the treatment of equine recurrent uveitis
8 Feb 2018
No longer Authorized signatory (ppa) (2) · Authorized signatory (ppa) (1)
11 Jan 2018 via Bayer Beteiligungsverwaltungsgesellschaft mbH & Co. OHG
General partner: Bayer Beteiligungsverwaltungsgesellschaft mbH & Co. OHG
1 Jan 2018 in Fk
Public funding (€180,352): SMITH - Medical Informatics Consortium - Contribution from Bayer AG
31 Dec 2017
Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017
Year 2017 in Epobase
43 European patent filings: Novel Hepcidin Mimetics and Uses Thereof …
Year 2017 in Dpmam
121 trademark filings (18 wordmarks, 3 figurative marks, 2 word figurative marks): "Instantin", ACTRON, AKTREN, ALKA-AntiGas, ALKA-Balance, ALKA-GasEx, ALKA-Gastrol, ALKA-Mints, ASPIRIN, ASPIRIN …
Year 2017 in Euipotm
72 trademark filings (67 wordmarks, 4 figurative marks, 1 word figurative mark): ABILEUM, AKRENDO, ALZBAY, AMESOTUR, ARAVMESO, BAYER SCHERING PHARMA, BAYSYSTEMS, CALEY, CAMBRIVA, CASSIPLA, CEMBRIUS …
Year 2017 in Dpmap
5 patent filings (1 Patent, 1 utility patent): Anti-angiogenic substances for the treatment of equine recurrent uveitis …
1 Dec 2017
No longer Authorized signatory (ppa): Konstanze Diefenbach
17 Oct 2017
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (5)
6 Oct 2017
List of board members
2 Oct 2017
Original document: “Liste der Aufsichtsratsmitglieder zum 02.10.2017“
Year 2017 in Hor
7 EU fundings (€0.00): Develop and validate appropriate and acceptable outcome measures in intermediate age-related macular degeneration for future interventional clinical trials - Sofia ref.: 116076 …
10 Jul 2017
Authorized signatory (ppa) (2) · No longer Authorized signatory (ppa) (1)
20 Jun 2017
Authorized signatory (ppa) (7) · No longer Authorized signatory (ppa) (1)
20 Jun 2017
List of board members
7 Jun 2017
Original document: “Liste der Aufsichtsratsmitglieder zum 07.06.2017“
17 May 2017
Consolidated Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016 · Shareholdings (393 companies)
9 May 2017 via Bayer CropScience AG
Control: Bayer CropScience AG
8 May 2017
Company statute
3 May 2017
Authorized signatory (ppa) (4) · No longer Authorized signatory (ppa) (2)
3 May 2017
List of board members
2 May 2017
Original document: “Liste der Aufsichtsratsmitglieder zum 02.05.2017“
28 Apr 2017
Annual report for the year ending 31/12/2016
28 Apr 2017
Original document: “Gesellschaftsvertrag / Satzung / Statut“
26 Apr 2017
Authorized signatory (ppa) (1)
11 Apr 2017
Authorized signatory (ppa) (9) · No longer Authorized signatory (ppa) (4)
11 Apr 2017
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016 · Change of shareholdings (197 companies)
17 Feb 2017
Authorized signatory (ppa) (3)
25 Jan 2017
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (5)
6 Jan 2017
Authorized signatory (ppa) (101) · No longer Authorized signatory (ppa) (1)
31 Dec 2016
Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016
Year 2016 in Dpmam
19 trademark filings (3 wordmarks, 1 figurative mark, 1 word figurative mark): ARPASS, ASCENSIA, BAYER, BAYER VISITORY, Bay-D-Best, Baysel, DIABCONTROL, FINE, HEALTHHOUSE, KARMEL, LIMITRIS, LYTTRON …
23 Dec 2016 via Currenta GmbH & Co. OHG
Shareholding: Currenta GmbH & Co. OHG
23 Dec 2016 in Fts
EU funding (€986.14): Meetings and Experts Groups Expenses 2017
Year 2016 in Epobase
9 European patent filings: Disposable Separator for Retention and Recirculation of Cells …
25 Nov 2016
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (5)
11 Oct 2016
Member of the Executive Board: Kemal Zulfiqar Malik · Authorized signatory (ppa) (11) · No longer Authorized signatory (ppa) (3)
1 Oct 2016 in Hor
EU funding: Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966
1 Sept 2016 in Hor
EU funding: Biomarker Enterprise to Attack DKD - Sofia ref.: 115974
15 Jul 2016
Authorized signatory (ppa) (1)
8 Jul 2016
Authorized signatory (ppa) (37)
8 Jul 2016 via Elanco Animal Health GmbH
Merger, No longer Control: Bayer Animal Health GmbH
1 Jul 2016
Merger: Bayer Technology Services GmbH
1 Jul 2016
Merger: Bayer HealthCare AG
1 Jul 2016 via Bayer Technology Services GmbH
Control, Profit Transfer, Merger: Bayer Technology Services GmbH
20 Jun 2016
Wordmark: “CANESTEN“
Year 2016 in Fk
4 German state fundings (€842,949): Energie- und Ressourceneinsparung durch innovative und CFD-basierte Auslegung von Flüssig/Flüssig-Schwerkraftabscheidern (ERICAA), Teilvorhaben …
1 Jun 2016
Patent: Einrichtung zum Transport von Mikrotitrationsplatten in einem Handlingsautomat
4 May 2016
Authorized signatory (ppa): Bernd-Peter Bier, Armin Knors · No longer Authorized signatory (ppa) (2) · No longer Member of the Executive Board (1)
4 May 2016
List of board members
2 May 2016
Original document: “Liste der Aufsichtsratsmitglieder zum 02.05.2016“
29 Apr 2016
Annual report for the year ending 31/12/2015
22 Apr 2016
Consolidated Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015 · Shareholdings (395 companies)
20 Mar 2016
Wordmark: “DESMOLUX“
14 Jan 2016
Patent: Groundable flexible bulk container
6 Jan 2016
No longer Authorized signatory (ppa): Liam Condon · Member of the Executive Board (4) · No longer Member of the Executive Board (1)
1 Jan 2016 in Fts
EU funding (€690.48): Expert Group Costs
31 Dec 2015
Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015
Year 2015 in Dpmam
1 word figurative mark: "Aspineurin", "Cresival", "Tiguvon", 1nject, ADVANTAGE, ADVANTIX, ADVOCATE, AMOXISOL, ARENTOR, ARMADOSE, AVICOL, BAYBEE, BAYCOX, BAYDOT, BAYERFARM …
23 Dec 2015
Patent: Reaktionskammer für einen Chemischen Reaktor und Hieraus Aufgebauter Chemischer Reaktor
23 Dec 2015
Patent: Reaktionskammer für einen Chemischen Reaktor und Hieraus Aufgebauter Chemischer Reaktor
Year 2015 in Euipotm
10 trademark filings (8 wordmarks, 2 word figurative marks): BAYDOT, BayBC, BayCC, BayTubes, CANESNAIL, CCR, FANTASIA, LEXSY@LIVE …
18 Dec 2015 via Bayer HealthCare AG
Merger: Bayer HealthCare AG
17 Dec 2015
Merger: Bayer Technology Services GmbH
17 Dec 2015
Merger: Bayer HealthCare AG
16 Dec 2015
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
16 Dec 2015
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
16 Dec 2015
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
16 Dec 2015
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
16 Dec 2015
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
16 Dec 2015
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
16 Dec 2015
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
16 Dec 2015
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
16 Dec 2015
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
16 Dec 2015
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
16 Dec 2015
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
16 Dec 2015
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
13 Nov 2015
List of board members
Year 2015 in Epobase
7 European patent filings: Secondary Electron Multipliers and Methods for Producing One …
11 Nov 2015
Original document: “Liste der Aufsichtsratsmitglieder zum 11.11.2015“
4 Sept 2015
No longer Authorized signatory (ppa) (7)
Year 2015 in Fk
5 German state fundings (€1,503,140): MiMEP: Micromass spectrometer for increasing energy efficiency in the chemical process industry (MiMEP). Subproject: Process Requirements and Simulation …
Year 2015 in Hor
5 EU fundings (€1,569,943): Advancing Modelling for Process-Product Innovation, Optimization, Monitoring and Control in Life Science Industries …
9 Jul 2015
List of board members
9 Jul 2015
List of board members
3 Jul 2015
Authorized signatory (ppa) (1)
1 Jul 2015
Original document: “Liste der Aufsichtsratsmitglieder zum 01.07.2015“
26 Jun 2015
Authorized signatory (ppa) (4) · No longer Authorized signatory (ppa) (4)
24 Jun 2015
Registration of the object supplemented ex officio: The object of the undertaking is the production, distribution …
5 Jun 2015
Company statute · Corporate Purpose
1 Jun 2015
Original document: “Gesellschaftsvertrag / Satzung / Statut“
27 May 2015
Annual report for the year ending 31/12/2014
21 May 2015
Patent: Verfahren zum Betreiben einer zur Durchführung von Wenigstens einer Chemischen Reaktion Eingerichteten Anlage
21 Apr 2015
Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014 · Shareholdings (196 companies)
21 Apr 2015
Consolidated Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014 · Shareholdings (394 companies)
2 Feb 2015
No longer Authorized signatory (ppa) (1)
28 Jan 2015
No longer Authorized signatory (ppa) (4)
1 Jan 2015 in Fts
EU funding (€747.10): Expert Groups Costs
31 Dec 2014
Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014
Year 2014 in Dpmam
255 trademark filings (3 figurative marks, 3 other marks): "Baygal", "Ugurol", "Vulkollan", ADALONG, ALKYDAL, AMIS, ARCOL, ARIA, ARTWALK, ASTER, AURA, AUTOcreative, AXXELLUM, AZAR, Alkynol …
Year 2014 in Dpmap
15 patent filings: Process for the preparation of alkylhalosilanes …
Year 2014 in Euipotm
11 trademark filings (9 wordmarks, 1 word figurative mark, 1 other mark): BAYSIZE, BAYSYSTEMS, BayMAP, Baycovin, DAMINEX, MORE TIME FOR WHAT MATTERS, MYLACERT, PEDW, PEP Technology Programmable …
15 Oct 2014
List of board members
14 Oct 2014
Original document: “Liste der Aufsichtsratsmitglieder zum 14.10.2014“
1 Oct 2014 in Fk
Public funding (€93,769): Professional Professionalism in the Manufacturing Industry (Brofessio), sub-project Development and testing of the Medi-ALP concept for age-appropriate competence development
8 Sept 2014
Member of the Executive Board: Johannes Dietsch · Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (6)
1 Sept 2014 in Fk
Public funding (€80,597): AGATA: Analysis of large amounts of data in processing processes
1 Sept 2014 in Fk
Public funding (€97,719): Energy Efficiency and Process Acceleration for the Chemical Industry - Improved Energy Efficiency and Process Acceleration through Data Integration from Process Development …
30 May 2014 via Bayer Technology Services GmbH
Control, Profit Transfer: Bayer Technology Services GmbH
26 May 2014 via Bayer Real Estate GmbH
Control, Profit Transfer: Bayer Real Estate GmbH
26 May 2014 via Zweite K-W-A Beteiligungsgesellschaft mbH
Profit Transfer: Zweite K-W-A Beteiligungsgesellschaft mbH
26 May 2014 via Bayer Innovation GmbH
Control, Profit Transfer: Bayer Innovation GmbH
26 May 2014 via Bayer US IP GmbH
Control, Profit Transfer: Bayer US IP GmbH
23 May 2014 via Erste K-W-A Beteiligungsgesellschaft mbH
Profit Transfer: Erste K-W-A Beteiligungsgesellschaft mbH
23 May 2014 via Bayer Bitterfeld GmbH
Profit Transfer: Bayer Bitterfeld GmbH
16 May 2014
Authorized signatory (ppa) (3) · No longer Member of the Executive Board (1) · Company statute
7 May 2014
List of board members
5 May 2014
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013 · Shareholdings (192 companies)
5 May 2014
Consolidated Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013 · Shareholdings (383 companies)
5 May 2014
Original document: “Liste der Aufsichtsratsmitglieder zum 05.05.2014“
29 Apr 2014
Original document: “Gesellschaftsvertrag / Satzung / Statut“
7 Mar 2014
Patent: Method for handling deflagratable solids
21 Feb 2014
Member of the Executive Board: Kemal Zulfiqar Malik · No longer Authorized signatory (ppa) (2)
31 Dec 2013
Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013
23 Dec 2013
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (1) · Company statute
Year 2013 in Euipotm
16 trademark filings (14 wordmarks, 1 figurative mark, 1 word figurative mark): ASRELOM, BAYCOSMETICS, BAYER, CELTRILOR, CEOVEC, DESMONATE, DESMOPOL, DYNEVO, IXALION, NEVRILAM, NUVARDEN, OQUAVEL …
Year 2013 in Dpmam
56 trademark filings (1 wordmark, 3 figurative marks, 2 word figurative marks): A D M I R E, ADALAT UNA, ADUNISA, ARPLINIS, ATLESS, ATLETOL, Aspineuran, Atosil, BAYER, BAYROPOL, BHC, BLIXEVE, Baygran …
1 Nov 2013 in Fk
Public funding (€447,237): Dream Compound - One-Polymer Fiber Matrix Composite
12 Sept 2013
Original document: “Gesellschaftsvertrag / Satzung / Statut“
29 Aug 2013
Patent: Einweg Abscheider zur Rückhaltung und Rückführung von Zellen
14 Aug 2013
No longer Authorized signatory (ppa) (4) · Authorized signatory (ppa) (2)
24 Jun 2013
Authorized signatory (ppa) (4) · No longer Authorized signatory (ppa) (2) · No longer Member of the Executive Board (1)
24 Jun 2013 via Bayer Beteiligungsverwaltung Goslar GmbH
Control, Profit Transfer: Bayer Beteiligungsverwaltung Goslar GmbH
12 Jun 2013
Authorized signatory (ppa) (1)
6 Jun 2013
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (7) · Member of the Executive Board (1)
4 Jun 2013
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (7) · Member of the Executive Board (1)
17 May 2013
Consolidated Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012 · Shareholdings (392 companies)
10 May 2013
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012 · Shareholdings (194 companies)
24 Jan 2013
Patent: Reflection probe
1 Jan 2013 in Fk
Public funding (€283,907): PREDICT - Multiscale Modelling of the Effect of Targeted Protein Therapeutics: Towards Predictive Cancer Therapy - Subproject C
31 Dec 2012
Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012
Year 2012 in Dpmam
481 trademark filings (24 wordmarks, 1 figurative mark, 1 word figurative mark): ADAPSAL, ADENGO, ADUNISA, ADVASEAL, AGENDA, AGOLIN, AKTEUR, ALION, ALISTER, ALTRAZ, ALYTIL, AMAXIS, AMBITION, AMELYDIS …
Year 2012 in Euipotm
10 trademark filings (8 wordmarks, 1 figurative mark, 1 word figurative mark): ACTION, BAYTONE, CANESPRO, ENHANCING DIAGNOSIS. EMPOWERING CARE., Job@ctive, SensiChip, TOUCH THE FUTURE, VERCORA …
5 Oct 2012
List of board members
1 Oct 2012
Original document: “Liste der Aufsichtsratsmitglieder zum 01.10.2012“
19 Sept 2012
Patent: Rest frame for a multi-coupling for filling and/or emptying a chemical plant container
14 Aug 2012
Patent: Micro sampling system for small amounts of fluid samples for analysis in the vapor phase
10 Aug 2012 via Bayer Gesellschaft für Beteiligungen mbH also 09/08/2012
No longer Profit Transfer: Bayer Gesellschaft für Beteiligungen mbH
20 Jul 2012
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (3)
10 May 2012
Company statute
8 May 2012
List of board members
30 Apr 2012
Original document: “Liste der Aufsichtsratsmitglieder zum 30.04.2012“
27 Apr 2012
Annual report for the year ending 31/12/2011
27 Apr 2012
Original document: “Gesellschaftsvertrag / Satzung / Statut“
24 Apr 2012 via Bayer Intellectual Property GmbH also 19/04/2012, 13/12/2011
Merger: Bayer Intellectual Property GmbH
23 Apr 2012
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011 · Earnings statement for 31/12/2011 · Shareholdings (188 companies)
23 Apr 2012
Consolidated Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011 · Earnings statement for 31/12/2011 · Shareholdings (385 companies)
27 Feb 2012
Authorized signatory (ppa) (1)
10 Feb 2012
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (4)
17 Jan 2012 via Elanco Animal Health GmbH
No longer Profit Transfer: Bayer Animal Health GmbH
1 Jan 2012 in Fk
Public funding (€842,271): Ultrafast Cellular High-Throughput Screening with Subcellular Resolution (u2-HTS) - Subproject: High-Resolution Imaging, Evanescent Excitation in Cellular Assays, System …
31 Dec 2011
Balance sheet for 31/12/2011 · Earnings statement for 31/12/2011
15 Dec 2011 via Neunte Bayer VV GmbH
Control, Profit Transfer, Merger: Neunte Bayer VV GmbH
9 Dec 2011 via Erste K-W-A Beteiligungsgesellschaft mbH
Control, Profit Transfer: Erste K-W-A Beteiligungsgesellschaft mbH
9 Dec 2011 via Siebte Bayer VV GmbH
Control, Profit Transfer, Merger: Siebte Bayer VV GmbH
Year 2011 in Euipotm
14 trademark filings (12 wordmarks, 2 figurative marks): ARTIFICIAL MUSCLE, ASKIVIA, AXARALL, BAYSIL, CREATING WONDERS, JOKI, MICROACTIVE, NAAP, NEVER LOSING SIGHT OF THE HUMAN FACTOR, PERSONALIZED …
Year 2011 in Dpmam
109 trademark filings (12 wordmarks, 2 figurative marks, 2 word figurative marks): "Germanin", ACOMPLEX, ADVANEM, ALHAMBRA, AMOLI, ANDURAN, ARTURO, ASKIVIA, ASPIRIN CARDIO, ASTROLUX, AXENTEC, BARITON …
22 Sept 2011
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (3)
9 Sept 2011
Merger: Sechste Bayer VV GmbH
9 Sept 2011 via Sechste Bayer VV GmbH
Merger: Sechste Bayer VV GmbH
29 Jul 2011
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
28 Jul 2011
Merger: Sechste Bayer VV GmbH
25 Jul 2011
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
5 Jul 2011 via Bayer Real Estate GmbH
Acquisition, Spin-off: Bayer Real Estate GmbH
5 Jul 2011
Acquisition: Bayer Real Estate GmbH · Spin-off: Bayer Real Estate GmbH
10 May 2011
Company statute
29 Apr 2011
Annual report for the year ending 31/12/2010
29 Apr 2011
Original document: “Gesellschaftsvertrag / Satzung / Statut“
27 Apr 2011
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010 · Earnings statement for 31/12/2010 · Shareholdings (195 companies)
27 Apr 2011
Consolidated Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010 · Earnings statement for 31/12/2010 · Shareholdings (388 companies)
19 Apr 2011
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (2)
via Ora in Ora
Partner: Schering Slovakia s.r.o. · No longer Partner: Schering Slovakia s.r.o.
28 Feb 2011
Spin-off: Bayer Real Estate GmbH
17 Feb 2011
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
17 Feb 2011
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
17 Feb 2011
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
17 Feb 2011
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
17 Feb 2011
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
17 Feb 2011
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
12 Jan 2011 via Bayfin GmbH
No longer Control, No longer Profit Transfer: Bayfin GmbH
31 Dec 2010
Balance sheet for 31/12/2010 · Earnings statement for 31/12/2010
Year 2010 in Dpmam
186 trademark filings (72 wordmarks, 2 figurative marks): "Prominal", AFORTIX, AGILOFLEX, ALBAY, ALZALUMA, ALZITRACE, AMRIFEL, AMYMARQ, ASKIVIA, AXARALL, Acarbay, Adiro, Algeril, BARONET, BAYARENA …
Year 2010 in Euipotm
10 trademark filings (9 wordmarks, 1 figurative mark): ADVISE, F279, FIBROCALC, FIBROCLEAR, FIBROMET, FIBROZAC, REVASTARA, XOFIGO …
20 Oct 2010
Authorized signatory (ppa) (1)
14 Oct 2010
Authorized signatory (ppa) (5) · No longer Authorized signatory (ppa) (3) · No longer Member of the Executive Board (1)
1 Oct 2010 in Fk
Public funding (€2,768,857): Utilisation of CO2 as a carbon building block using predominantly renewable energy - Subproject 1
17 Sept 2010
Patent: Method and device for connecting a flexible profiled hollow cylinder with a cylindrical body, as well as subsequently manufactured irradiation modules
4 Aug 2010
Patent: Substituted benzoylcyclohexenones and their use as herbicidal agents
23 Jul 2010 via Allianz Lebensversicherungs-AG also 10/08/2009, 29/09/2008, 08/08/2007
Shareholder: Allianz Lebensversicherungs-AG
16 Jul 2010
No longer Authorized signatory (ppa) (3) · Authorized signatory (ppa) (1)
14 Jul 2010
List of board members
6 Jul 2010
Original document: “Liste der Aufsichtsratsmitglieder zum 06.07.2010“
17 Jun 2010
Patent: Method and device for connecting a flexible profiled hollow cylinder with a cylindrical body, as well as subsequently manufactured irradiation modules
8 Jun 2010
The share capital was increased by resolution of the Annual General Meeting on 30.04.2010 by up to Euro 211,698,560.00 …
2 Jun 2010
Patent: Flammenionisationsdetektor
18 May 2010
Company statute
10 May 2010
No longer Member of the Executive Board (1)
30 Apr 2010
Annual report for the year ending 31/12/2009
30 Apr 2010
Original document: “Gesellschaftsvertrag / Satzung / Statut“
29 Apr 2010
Authorized signatory (ppa) (5) · No longer Authorized signatory (ppa) (8)
15 Apr 2010
Consolidated Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009 · Earnings statement for 31/12/2009 · Shareholdings (201 companies)
14 Apr 2010
Consolidated Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009 · Earnings statement for 31/12/2009 · Shareholdings (406 companies)
9 Apr 2010 via Bayer Animal Health Studies GmbH
No longer Control, No longer Profit Transfer: Bayer Animal Health Studies GmbH
1 Apr 2010 in Fk
Public funding (€1,142,347): Competence Network 'The Virtual Liver' Subprojects E and G
17 Mar 2010 via Allianz SE also 02/05/2008, 02/01/2008
Shareholder: Allianz SE
26 Jan 2010
Company statute
19 Jan 2010
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (1) · Company statute
8 Jan 2010
Member of the Executive Board (2)
4 Jan 2010
Original document: “Gesellschaftsvertrag / Satzung / Statut“
31 Dec 2009
Balance sheet for 31/12/2009 · Earnings statement for 31/12/2009
31 Dec 2009 via Industrial and Commercial Bank of China Ltd. Frankfurt Branch
Shareholder: Industrial and Commerical Bank of China Ltd. Frankfurt Branch
Year 2009 in Dpmam
107 trademark filings (39 wordmarks, 2 figurative marks, 3 word figurative marks): ADEMPAS, ADEMSOS, AMETASE, ARTIMSA, AVALOX, AVOLOX, AZINTREL, BAYDECO, BAYFAME, BAYPAMUNE, BAYSOLV, BAYVENIL …
Year 2009 in Euipotm
12 trademark filings (6 wordmarks, 5 figurative marks, 1 word figurative mark): ALION, BAYASPIRINA, EYLEA, NECANDID, NECANYX, SULF 02 BAY …
11 Nov 2009
Patent: Polyurethane ureas useful for the production of spandex and a process for their preparation
21 Sept 2009
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
15 Sept 2009
The conditional capital resolved at the Annual General Meeting on 30.04.2004 amounts to ...
15 Sept 2009
Company statute
27 Aug 2009
List of board members
19 Aug 2009
Original document: “Liste der Aufsichtsratsmitglieder zum 19.08.2009“
6 Jul 2009
Authorized signatory (ppa) (4) · No longer Authorized signatory (ppa) (3)
30 Jun 2009
Original document: “Gesellschaftsvertrag / Satzung / Statut“
26 Jun 2009
Original document: “Gesellschaftsvertrag / Satzung / Statut“
12 May 2009
Annual report for the year ending 31/12/2008
8 May 2009
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008 · Earnings statement for 31/12/2008 · Change of shareholdings (209 companies)
8 May 2009
Consolidated Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008 · Earnings statement for 31/12/2008 · Shareholdings (407 companies)
6 Mar 2009
Capital: €1.96B
3 Mar 2009 via CaseTech GmbH & Co. KG
Shareholder: CaseTech GmbH & Co. KG
2 Mar 2009
Original document: “Gesellschaftsvertrag / Satzung / Statut“
24 Feb 2009
Due to the conditional increase in the share capital resolved on 30.04.2004, subscription shares with a nominal value …
16 Feb 2009
Patent: Method and device for connecting a flexible profiled hollow cylinder with a cylindrical body, as well as subsequently manufactured irradiation modules
4 Feb 2009
No longer Authorized signatory (ppa) (4) · Address
27 Jan 2009
Original document: “Liste der Gesellschafter“
21 Jan 2009
Original document: “Liste der Gesellschafter“
19 Jan 2009
Original document: “Liste der Gesellschafter“
9 Jan 2009 via Bayer US IP GmbH
Control, Profit Transfer, Merger: BayInvest GmbH
31 Dec 2008
Balance sheet for 31/12/2008 · Earnings statement for 31/12/2008
Year 2008 in Euipotm
13 trademark filings (10 wordmarks, 3 word figurative marks): ACCUFLEX, BAYQIK, BayerCare, EYLIA, IPROVALS, LARISTA, Science For A Better Life, UVivatec, WISTRACT, XOFIGO …
Year 2008 in Dpmam
169 trademark filings (69 wordmarks, 2 figurative marks, 4 word figurative marks): "Impletol", ACCORD, ACTIRA, ACTIVOLAX, AGVENTURE, AIRDRIVER, AIRSPACE, AKAMIKA, AKTIVAR, ALANTO, ALITAR …
10 Dec 2008 via Bayer Pharma AG also 09/12/2008
Control, Profit Transfer, Merger: Bayer Schering Pharma AG
8 Dec 2008
Merger: Bayer Schering GmbH
8 Dec 2008 via Bayer Schering GmbH
Merger: Bayer Schering GmbH
1 Dec 2008
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
10 Nov 2008
Vorgänge ohne Eintragung vom 04.11.2008
23 Oct 2008
Financial Report as of September 30, 2008
23 Oct 2008
Financial report as of September 30, 2008
29 Sept 2008
Original document: “Gesellschaftsvertrag / Satzung / Statut“
16 Sept 2008
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (1)
10 Sept 2008
Patent: Method for accelerating the mucus dissolution rate
26 Aug 2008
Consolidated Annual report for the year ending 30/06/2008 · Balance sheet for 30/06/2008 · Earnings statement for 30/06/2008
28 Jul 2008
Shareholding: Bayer Schering Pharma AG
1 Jul 2008
Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007 · Earnings statement for 31/12/2007 · Shareholdings (109 companies)
1 Jul 2008
Consolidated Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007 · Earnings statement for 31/12/2007 · Shareholdings (223 companies)
25 Jun 2008
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (2)
15 May 2008
Authorized signatory (ppa) (2) · No longer Authorized signatory (ppa) (1) · Company statute
8 May 2008 via Bayer Animal Health Studies GmbH
Control, Profit Transfer: Fünfte Bayer VV GmbH
30 Apr 2008
Patent: Modified cytokinin for its stabilization
30 Apr 2008
Original document: “Gesellschaftsvertrag / Satzung / Statut“
23 Apr 2008
Patent: Vorrichtung zur Bestrahlung von Flüssigkeiten
31 Mar 2008 via Faserwerke Hüls GmbH
Shareholding: Faserwerke Hüls GmbH
16 Jan 2008
Original document: “Liste der Gesellschafter“
15 Jan 2008
Original document: “Gesellschaftsvertrag / Satzung / Statut“
31 Dec 2007
Balance sheet for 31/12/2007 · Earnings statement for 31/12/2007
Year 2007 in Euipotm
11 wordmarks: BAYPHOSPHINE, BAYQOL, CELESTIA, DESMODUR TB 1, EXTRACT, LIPOBAY, MENEVIT, RECORD, SHAKE, VALUGA, VERICOR
Year 2007 in Dpmam
109 trademark filings (10 wordmarks, 4 figurative marks, 3 word figurative marks): "Mitigal", "Phanodorm", ACTIVHALER, AIM - Assistant for Office Management, ALZBAY, ANTENEF, ARCHIV, ARRIBA …
4 Dec 2007
No longer Authorized signatory (ppa) (6) · Authorized signatory (ppa) (2)
24 Oct 2007
Patent: Vorrichtung zur Erzeugung einer Grösstmöglichen Phasengrenzfläche zur Kontinuierlichen und Hocheffizienten Durchmischung Unterschiedlicher Fluide in GAS-Flüssigkeits-Gemischen
10 Sept 2007
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006 · Earnings statement for 31/12/2006 · Shareholdings (114 companies)
10 Sept 2007
Consolidated Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006 · Earnings statement for 31/12/2006 · Shareholdings (257 companies)
8 Aug 2007
Authorized signatory (ppa) (7) · No longer Authorized signatory (ppa) (4)
27 Jul 2007
No longer Authorized signatory (ppa) (1)
20 Jul 2007
Patent: Optical measuring probe for process monitoring
11 Jul 2007
Patent: Diagnosis of liver fibrosis using serum marker algorithms
18 May 2007
By resolution of the Annual General Meeting on 27.04.2007, § 4 (share capital) paragraph 3 was repealed and recast
11 May 2007
List of board members
7 May 2007
Original document: “Gesellschaftsvertrag / Satzung / Statut“
2 May 2007
Shareholder: Bayer Schering Pharma AG
2 May 2007
Konzern-Quartalsbericht zum 31. März 2007
30 Apr 2007
Original document: “Liste der Aufsichtsratsmitglieder zum 30.04.2007“
17 Apr 2007
Patent: Process analysis system with sterile sampling of mechanically sensitive material from a bioreactor
9 Mar 2007
Authorized signatory (ppa) (2)
7 Mar 2007
List of board members
23 Feb 2007
Original document: “Liste der Aufsichtsratsmitglieder zum 23.02.2007“
5 Feb 2007
No longer Authorized signatory (ppa) (13) · Authorized signatory (ppa) (2)
31 Dec 2006
Balance sheet for 31/12/2006 · Earnings statement for 31/12/2006
Year 2006 in Dpmam
126 trademark filings (14 wordmarks, 3 figurative marks): AMIS, AVIGUARD, AXIOM, Acralen, BAYARD, BAYFIX, BAYHYDRAL, BAYLOXAN, BAYMYCARD, BAYPHOB, BAYPHOSPHINE, BAYPHYTO, BAYQIK, BAYSCENT, BAYSIS …
15 Dec 2006
Wordmark: “COMLOG“
Year 2006 in Epobase
6 European patent filings: Polyurethane-Urea Fibres with Improved Resistance …
22 Nov 2006
Patent: Vorrichtung zur Zeitlichen Dosierung von Arzneistoffen
31 Oct 2006
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (1)
18 Jul 2006
Capital: €1.96B
13 Jun 2006
Authorized signatory (ppa): Jörg Thomaier · No longer Member of the Executive Board (1)
6 Jun 2006 via Bayfin GmbH also 30/05/2006
Control, Profit Transfer: Bayfin GmbH
6 Apr 2006
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (2) · Member of the Executive Board (1)
29 Mar 2006
Wordmark: “TRODIXA“
17 Jan 2006
Wordmark: “TEVORAK“
31 Dec 2005
Balance sheet for 31/12/2005 · Earnings statement for 31/12/2005
29 Dec 2005
Company statute
Year 2005 in Dpmam
256 trademark filings (14 wordmarks, 2 word figurative marks): "Preventol", "SUPRANOL", "Solbrol", "Vulkacit", ABOLEN, ACRAMOLL, ALADIN, ANHYMIX, ANHYPOR, AQUADERM, ATLAS, Acraconz, Acrafix, Acramin …
Year 2005 in Epobase
22 European patent filings: Modulation of angiogenesis by using anti-angiogenic angiotensin-7 and polynucleotides encoding the same for the treatment of tumors …
15 Nov 2005
Authorized signatory (ppa) (2) · Company statute
4 Oct 2005
Authorized signatory (ppa): Andreas Kaiser · No longer Authorized signatory (ppa) (8)
15 Sept 2005
Patent: Vorrichtung zur Zeitlichen Dosierung von Arzneistoffen
14 Jun 2005
Authorized signatory (ppa) (6) · No longer Authorized signatory (ppa) (6) · Company statute
10 Jun 2005
Wordmark: “KIRENT“
14 Apr 2005
Patent: Verfahren zur Simulation der Wechselwirkung von Chemischen Substanzen mit Lebenden Organismen
1 Mar 2005
No longer Authorized signatory (ppa) (10)
22 Feb 2005
Wordmark: “BUNALON“
21 Feb 2005
Wordmark: “Cheminspect“
8 Feb 2005
Acquisition: LANXESS AG · Break-up: LANXESS AG
25 Jan 2005
Authorized signatory (ppa) (6)
6 Dec 2004
Authorized signatory (ppa) (1)
27 Jul 2004
Authorized signatory (ppa) (1)
14 Jul 2004
Authorized signatory (ppa) (17) · No longer Authorized signatory (ppa) (1)
11 Mar 2004
No longer Authorized signatory (ppa) (45)
30 Dec 2003
Acquisition (3 companies) · Spin-off (3 companies)
26 Nov 2003
No longer Authorized signatory (ppa) (43) · Authorized signatory (ppa) (2)
30 Sept 2003
Acquisition: Bayer Chemicals AG · Spin-off: Bayer Chemicals AG
8 Jul 2003
Member of the Executive Board (1)
1 Jul 2003
Authorized signatory (ppa) (6) · No longer Authorized signatory (ppa) (10)
14 May 2003
Company statute
6 May 2003
Authorized signatory (ppa) (33) · No longer Authorized signatory (ppa) (11) · No longer Member of the Executive Board (1)
21 Mar 2003
Authorized signatory (ppa) (35) · No longer Authorized signatory (ppa) (10)
19 Mar 2003
Reg­is­tra­tion · Member of the Executive Board (5) · Authorized signatory (ppa) (45) · Seat: Leverkusen · Legal form: AG · Name: Bayer AG · Proxy policy · Corporate Purpose
19 Jun 1987 as Bayer AG Buiv in Belgium
Miscellaneous
1 Feb 1986 as Bayer AG Buiv in Belgium
Miscellaneous
26 Feb 1985 as Bayer AG Buiv in Belgium
Miscellaneous
There are no publications matching your search.

Mentions

in Ler
Direct parent (131 companies) · No longer Direct parent (13 companies)
in Ler
Ultimate parent (135 companies) · No longer Ultimate parent (15 companies)
13 Jan 2026 in Or
No longer Partner: Bayer s.r.o
via Companies House in Psc
2 Jan 2025 in Hrcdd
No longer Control, No longer Profit Transfer: Zweite K-W-A Beteiligungsgesellschaft mbH
27 Nov 2024 in Hrdk
Gene and Cell Therapies Incubator Berlin GmbH: “Liste der Gesellschafter“
15 Nov 2024 in Hrcdd
Limited Partner: High-Tech Gründerfonds III GmbH & Co. KG
13 Nov 2024 in Hrcdd also 21/07/2022
Limited Partner: High-Tech Gründerfonds IV GmbH & Co. KG
3 Jun 2024 in Hrdk
Ada Health GmbH: “Liste der Gesellschafter“
31 May 2024 in Hrcdd
Control, Profit Transfer: Bayer CropScience AG
23 Apr 2024 in Vr
Shareholding: Schering s.r.o.-Člen Koncernu
25 Mar 2024 in Vr
Shareholding: Bayer s.r.o
Year 2022 in Hrdk
Shareholdings (8 companies)
Year 2021 in Hrdk
Shareholdings (6 companies)
Year 2020 in Hrdk also 02/11/2011
Shareholdings (4 companies)
Year 2017 in Hrdk
Shareholdings (16 companies)
Year 2017 in Hrcdd
Profit Transfer: Ehrfeld Mikrotechnik GmbH · Control: Ehrfeld Mikrotechnik GmbH · Company lease · No longer Control · No longer Profit Transfer
16 Aug 2016 in Hrdk
INVITE GmbH: “Liste der Gesellschafter“
9 Jul 2015 in Hrdk
Covestro First Real Estate GmbH: “Liste der Gesellschafter“
Year 2012 in Hrdk also 29/12/2008
Shareholding
Year 2009 in Hrdk
Shareholdings (10 companies)
7 Aug 2009 in Hrcdd
General partner: Currenta GmbH & Co. OHG
13 Oct 2005 in Hrcdd
Limited Partner: KG III Augusta Grundstücksverwaltungsgesellschaft mbH & Co. KG
27 Apr 2005 in Hrcdd
No longer Limited Partner: Exatec GmbH & Co.KG
24 Jun 2004 in Hrcdd
Control, Profit Transfer: Bayer Gesellschaft für Beteiligungen mbH
8 Jun 2004 in Hrcdd
Control, Profit Transfer: GeWoGe Gesellschaft für Wohnen und Gebäudemanagement mbH
Year 2003 in Hrcdd
Control · General partner: Bayer Standort Dienste GmbH & Co. OHG · Limited Partner: Exatec GmbH & Co.KG · Acquisition · Spin-off · Profit Transfer (4 companies)
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.